Clinical Trials List
2019-09-01 - 2024-05-14
Phase III
Terminated8
ICD-10M32.0
Drug-induced systemic lupus erythematosus
ICD-10M32.10
Systemic lupus erythematosus, organ or system involvement unspecified
ICD-10M32.11
Endocarditis in systemic lupus erythematosus
ICD-10M32.12
Pericarditis in systemic lupus erythematosus
ICD-10M32.13
Lung involvement in systemic lupus erythematosus
ICD-10M32.14
Glomerular disease in systemic lupus erythematosus
ICD-10M32.15
Tubulo-interstitial nephropathy in systemic lupus erythematosus
ICD-10M32.19
Other organ or system involvement in systemic lupus erythematosus
ICD-10M32.8
Other forms of systemic lupus erythematosus
ICD-10M32.9
Systemic lupus erythematosus, unspecified
ICD-9710.0
Systemic lupus erythematosus
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 全以祖 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 蕭凱鴻 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林靖才 Division of General Internal Medicine
- WEN-NAN HUANG Division of General Internal Medicine
- 吳沂達 Division of General Internal Medicine
- HSIN-HUA CHEN Division of General Internal Medicine
- 譚國棟 Division of General Internal Medicine
- Yi-Ming Chen Division of General Internal Medicine
- 謝祖怡 Division of General Internal Medicine
- 洪維廷 Division of General Internal Medicine
- 謝佳偉 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHENG-HAN WU Division of General Internal Medicine
- 郭佑民 Division of General Internal Medicine
- CHIEH-YU SHEN Division of General Internal Medicine
- KO-JEN LI Division of General Internal Medicine
- 呂政勳 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chang-Fu Kuo Division of General Internal Medicine
- Yun Chen Tsai Division of General Internal Medicine
- 張哲慈 Division of General Internal Medicine
- TianMing Zhan Division of General Internal Medicine
- Yao-Fan Fang Division of General Internal Medicine
- Yun Ju Huang Division of General Internal Medicine
- Chen-I Hsieh Division of General Internal Medicine
- 陳彥輔 Division of General Internal Medicine
- Ping-Han Tsai Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
450 participants
